Cargando…
Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649033/ https://www.ncbi.nlm.nih.gov/pubmed/33213999 http://dx.doi.org/10.1016/j.mehy.2020.110380 |
| _version_ | 1783607237131894784 |
|---|---|
| author | Gargouri, Mohamed Alzwi, Aboubaker Abobaker, Anis |
| author_facet | Gargouri, Mohamed Alzwi, Aboubaker Abobaker, Anis |
| author_sort | Gargouri, Mohamed |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7649033 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76490332020-11-09 Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19 Gargouri, Mohamed Alzwi, Aboubaker Abobaker, Anis Med Hypotheses Article Elsevier Ltd. 2021-01 2020-11-08 /pmc/articles/PMC7649033/ /pubmed/33213999 http://dx.doi.org/10.1016/j.mehy.2020.110380 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Gargouri, Mohamed Alzwi, Aboubaker Abobaker, Anis Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19 |
| title | Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19 |
| title_full | Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19 |
| title_fullStr | Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19 |
| title_full_unstemmed | Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19 |
| title_short | Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19 |
| title_sort | cyclin dependent kinase inhibitors as a new potential therapeutic option in management of covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649033/ https://www.ncbi.nlm.nih.gov/pubmed/33213999 http://dx.doi.org/10.1016/j.mehy.2020.110380 |
| work_keys_str_mv | AT gargourimohamed cyclindependentkinaseinhibitorsasanewpotentialtherapeuticoptioninmanagementofcovid19 AT alzwiaboubaker cyclindependentkinaseinhibitorsasanewpotentialtherapeuticoptioninmanagementofcovid19 AT abobakeranis cyclindependentkinaseinhibitorsasanewpotentialtherapeuticoptioninmanagementofcovid19 |